Skip to main content

Table 1 Maternal and neonatal outcomes

From: Maternal circulating metabolic biomarkers and their prediction performance for gestational diabetes mellitus related macrosomia

Variables

GDM-M (n = 44)

GDM-N (n = 44)

P

Hospital stays (days)

6.2 ± 2.0

4.6 ± 1.3

<  0.001

Weight gain during pregnancy (kg)

13.5 ± 4.9

10.0 ± 3.2

<  0.001

Premature rupture of membrane

8 (18.2%)

0

0.009

Fetal distress

2 (4.5%)

0

0.474

Polyhydramnios

4 (9.1%)

0

0.125

Cesarean delivery

25 (56.8%)

14 (31.8%)

0.018

Intrapartum fever

4 (9.1%)

5 (11.4%)

1.000

Gestational weeks at birth

39.5 ± 0.9

39.0 ± 0.9

0.016

Birth weight (g)

4162.7 ± 141.7

3224.1 ± 301.7

< 0.001

1-min Apgar score < 10

1 (2.3%)

0

1.000

Postpartum hemorrhage

1 (2.3%)

1 (2.3%)

1.000

Postpartum fasting blood glucose (mmol/L)

4.9 ± 0.7

4.4 ± 0.5

0.016

Postpartum 2 h postprandial blood glucose (mmol/L)

5.8 ± 0.7

6.0 ± 1.6

0.539

Postpartum hemoglobin (g/L)

117.7 ± 14.9

124.1 ± 10.1

0.021

  1. GDM-M women with gestational diabetes mellitus and macrosomia, GDM-N women with gestational diabetes mellitus and normal neonatal weight